Clinical Trials Logo

Tobacco; Use, Harmful clinical trials

View clinical trials related to Tobacco; Use, Harmful.

Filter by:
  • None
  • Page 1

NCT ID: NCT04776863 Completed - Eye Manifestations Clinical Trials

Effect of Smokeless Tobacco on Anterior Segment

Start date: March 1, 2020
Phase:
Study type: Observational [Patient Registry]

Observational, comparative, cross-sectional study

NCT ID: NCT03037775 Recruiting - Clinical trials for Tobacco; Use, Harmful

The Influence of Electronic and Traditional Cigarettes Smoking on Hemodynamic Parameters

EPAPHemo
Start date: June 2015
Phase: N/A
Study type: Interventional

It is intended to examine 50 healthy volunteers aged 18 - 60 years. 12-hour abstinence from tobacco smoke, alcohol or coffee before the experiment will be required. The exclusion criteria are medical history of stroke, coronary artery disease, chronic heart failure, hypertension, peripheral vascular disease, atrial fibrillation, polyneuropathy, obesity (BMI> 30 kg/m2), the current active disease (eg. viral infection). Test subjects will actively inhale for 10 minutes tobacco or the e-cigarette smoke with nicotine fluid (18 mg/ml) or fluid without nicotine for 10 minutes. The study protocol involves random allocation to groups exposed to electronic or traditional cigarette smoke in cross-over scheme. The primary endpoint is the maximum change in heart rate compared to mean values prior to exposure. Secondary end points is the maximum change in the measured parameters (hemodynamic and autonomic values) compared to the average values before exposure. The measurements will be performed using the Task Force Monitor system for non-invasive measurement of hemodynamic parameters and the assessment of autonomic function. Adrenergic activity will be tested with microneurography. A periodic analysis is planned after examining 15 and 35 patients.